Portfolio

Top 10 Holdings as of 12/31/2019

Amgen, Inc. 7.1%
Gilead Sciences, Inc. 6.2%
Vertex Pharmaceuticals, Inc. 5.7%
Illumina, Inc. 5.1%
Biogen, Inc. 4.50%
Regeneron Pharmaceuticals, Inc. 4.13%
Alexion Pharmaceuticals, Inc. 2.6%
Bristol-Myers Squibb Co. 2.3%
Merck & Co., Inc. 2.2%
Seattle Genetics, Inc. 2.0%

This data is subject to change on a daily basis. Percentage is based on net assets.

Sub-Sector Allocation as of 12/31/2019

Biotechnology 60.2%
Pharmaceuticals 19.8%
Life Sciences Tools & Services 7.5%
Health Care Providers & Services 4.1%
Health Care Equipment & Supplies 3.9%
Medical Devices and Diagnostics 1.8%
Exchange Traded Funds 0.7%
Healthcare Services 0.6%
Repurchase Agreement 0.6%
Health Care Technology 0.2%
Drug Discovery Technologies 0.1%

This data is subject to change on a daily basis. Percentage is based on net assets.

Asset Allocation as of 12/31/2019

Common Stocks and Warrants 94.8%
Convertible Preferred and Warrants 1.9%
Milestone Interests 1.1%
Exchange Traded Funds 0.7%
Short-Term Investment 0.6%
Convertible Notes 0.4%
Other Assets In Excess Of Liabilities 0.5%

This data is subject to change on a daily basis. Percentage is based on net assets.